138 related articles for article (PubMed ID: 17592787)
1. Acute phase proteins as biological markers of negative psychopathology in paranoid schizophrenia.
Morera AL; Henry M; García-Hernández A; Fernández-López L
Actas Esp Psiquiatr; 2007; 35(4):249-52. PubMed ID: 17592787
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
[TBL] [Abstract][Full Text] [Related]
3. [Depressive symptoms in active phase of paranoid schizophrenia. Part II: Their link to positive symptoms].
Grzywa A; Karakuła H
Psychiatr Pol; 1998; 32(1):25-36. PubMed ID: 9594581
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE.
Steiner J; Walter M; Wunderlich MT; Bernstein HG; Panteli B; Brauner M; Jacobs R; Gos T; Rothermundt M; Bogerts B
Biol Psychiatry; 2009 Jun; 65(12):1107-10. PubMed ID: 19103440
[TBL] [Abstract][Full Text] [Related]
6. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of acute phase proteins in the plasma of patients with schizophrenia.
Yang Y; Wan C; Li H; Zhu H; La Y; Xi Z; Chen Y; Jiang L; Feng G; He L
Anal Chem; 2006 Jun; 78(11):3571-6. PubMed ID: 16737209
[TBL] [Abstract][Full Text] [Related]
8. [Active and prodromal phase symptomatology of young-onset and late-onset paranoid schizophrenia].
Skokou M; Katrivanou A; Andriopoulos I; Gourzis P
Rev Psiquiatr Salud Ment; 2012; 5(3):150-9. PubMed ID: 22854609
[TBL] [Abstract][Full Text] [Related]
9. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Akhondzadeh S; Malek-Hosseini M; Ghoreishi A; Raznahan M; Rezazadeh SA
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1879-83. PubMed ID: 18801405
[TBL] [Abstract][Full Text] [Related]
10. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
11. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
[TBL] [Abstract][Full Text] [Related]
12. [The factor structure of schizophrenic symptoms: which model is supported by independent item analysis?].
Ozel Kizil ET; Saka MC; Atbaşoğlu EC; Göğüş AK
Turk Psikiyatri Derg; 2008; 19(2):141-8. PubMed ID: 18561046
[TBL] [Abstract][Full Text] [Related]
13. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.
Hons J; Zirko R; Ulrychova M; Cermakova E; Libiger J
Neuro Endocrinol Lett; 2008 Aug; 29(4):485-92. PubMed ID: 18766161
[TBL] [Abstract][Full Text] [Related]
14. Co-morbid social phobia in schizophrenia.
Mazeh D; Bodner E; Weizman R; Delayahu Y; Cholostoy A; Martin T; Barak Y
Int J Soc Psychiatry; 2009 May; 55(3):198-202. PubMed ID: 19383663
[TBL] [Abstract][Full Text] [Related]
15. [Clinico-psychopathologic features and typology of acute paranoid episodes in schizophrenia].
Mukhin AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):236-43. PubMed ID: 3984610
[TBL] [Abstract][Full Text] [Related]
16. Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds.
Ostling S; Börjesson-Hanson A; Skoog I
Am J Geriatr Psychiatry; 2007 Dec; 15(12):999-1004. PubMed ID: 18056818
[TBL] [Abstract][Full Text] [Related]
17. Testosterone in first-episode schizophrenia.
Cesková E; Prikryl R; Kaspárek T
Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
[TBL] [Abstract][Full Text] [Related]
18. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
[TBL] [Abstract][Full Text] [Related]
19. EEG phase synchronization in patients with paranoid schizophrenia.
Bob P; Palus M; Susta M; Glaslova K
Neurosci Lett; 2008 Dec; 447(1):73-7. PubMed ID: 18835328
[TBL] [Abstract][Full Text] [Related]
20. Delusional discourse: an investigation comparing the spontaneous causal attributions of paranoid and non-paranoid individuals.
Lee DA; Randall F; Beattie G; Bentall RP
Psychol Psychother; 2004 Dec; 77(Pt 4):525-40. PubMed ID: 15588459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
